-
2
-
-
0022905604
-
Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine
-
Murphy SB, Bowman WP, Abromowitch M, Mirro J, Ochs J, Rivera G, Pui CH, Berard FD: Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986; 4: 1732-1739.
-
(1986)
J Clin Oncol
, vol.4
, pp. 1732-1739
-
-
Murphy, S.B.1
Bowman, W.P.2
Abromowitch, M.3
Mirro, J.4
Ochs, J.5
Rivera, G.6
Pui, C.H.7
Berard, F.D.8
-
3
-
-
49549102195
-
High-dose chemotherapy without stem cell transplantation for refractory childhood systemic lupus erythematosus
-
Luo XO, Mo Y, Ke ZY, Xu L, Jiang XY, Zhang TT, Chen SM: High-dose chemotherapy without stem cell transplantation for refractory childhood systemic lupus erythematosus. Chemotherapy 2008; 54: 331-335.
-
(2008)
Chemotherapy
, vol.54
, pp. 331-335
-
-
Luo, X.O.1
Mo, Y.2
Ke, Z.Y.3
Xu, L.4
Jiang, X.Y.5
Zhang, T.T.6
Chen, S.M.7
-
4
-
-
0020406634
-
Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)
-
Brock N, Stekar PJ, Scheef W: Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna). Eur J Cancer Clin Oncol 1982; 18: 1377-1387.
-
(1982)
Eur J Cancer Clin Oncol
, vol.18
, pp. 1377-1387
-
-
Brock, N.1
Stekar, P.J.2
Scheef, W.3
-
5
-
-
0032826199
-
An overview of cyclophosphamide development and clinical applications
-
Colvin OM: An overview of cyclophosphamide development and clinical applications. Curr Pharm Des 1999; 5: 555-560.
-
(1999)
Curr Pharm des
, vol.5
, pp. 555-560
-
-
Colvin, O.M.1
-
6
-
-
0032849465
-
The chemistry of the metabolites of cyclophosphamide
-
Ludeman SM: The chemistry of the metabolites of cyclophosphamide. Curr Pharm Des 1999; 5: 627-634.
-
(1999)
Curr Pharm des
, vol.5
, pp. 627-634
-
-
Ludeman, S.M.1
-
7
-
-
0034888045
-
Acute life-threatening toxicity of cancer treatment
-
Shanholtz C: Acute life-threatening toxicity of cancer treatment. Crit Care Clin 2001; 17: 483-502.
-
(2001)
Crit Care Clin
, vol.17
, pp. 483-502
-
-
Shanholtz, C.1
-
8
-
-
0018646130
-
Cyclophosphamideinduced cardiomyopathy: A report of two cases and review of the English literature
-
Mills BA, Roberts RW: Cyclophosphamideinduced cardiomyopathy: a report of two cases and review of the English literature. Cancer 1979; 4: 2223-2226.
-
(1979)
Cancer
, vol.4
, pp. 2223-2226
-
-
Mills, B.A.1
Roberts, R.W.2
-
9
-
-
0019823623
-
Cardiac changes with cyclophosphamide
-
Steinherz L, Steinherz PG, Mangiacasale G, O'Reilly R, Allen I, Sorell M, Miller DR: Cardiac changes with cyclophosphamide. Med Pediatr Oncol 1981; 9: 417-422.
-
(1981)
Med Pediatr Oncol
, vol.9
, pp. 417-422
-
-
Steinherz, L.1
Steinherz, P.G.2
Mangiacasale, G.3
O'Reilly, R.4
Allen, I.5
Sorell, M.6
Miller, D.R.7
-
10
-
-
84948007710
-
Cardiotoxicity associated with high-dose cyclophosphamide therapy
-
Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Zeigler J: Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 1981; 141: 758-763.
-
(1981)
Arch Intern Med
, vol.141
, pp. 758-763
-
-
Gottdiener, J.S.1
Appelbaum, F.R.2
Ferrans, V.J.3
Deisseroth, A.4
Zeigler, J.5
-
11
-
-
0022806838
-
Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor
-
Goldberg MA, Antin JH, Guinan EC, Rappeport JM: Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 1986; 68: 1114-1118.
-
(1986)
Blood
, vol.68
, pp. 1114-1118
-
-
Goldberg, M.A.1
Antin, J.H.2
Guinan, E.C.3
Rappeport, J.M.4
-
12
-
-
10644259704
-
Protective effect of DL-α-lipoic acid on cyclophosphamide induced oxidative cardiac injury
-
DOI 10.1016/j.cbi.2004.10.004, PII S0009279704001772
-
Mythili Y, Sudharsan PT, Selvakumar E, Varalakshmi P: Protective effect of DL- lipoic acid on cyclophosphamide induced oxidative cardiac injury. Chem Biol Interact 2004; 151: 13-19. (Pubitemid 39647933)
-
(2004)
Chemico-Biological Interactions
, vol.151
, Issue.1
, pp. 13-19
-
-
Mythili, Y.1
Sudharsan, P.T.2
Selvakumar, E.3
Varalakshmi, P.4
-
13
-
-
0024834475
-
Alterations of serum and urinary carnitine profiles in cancer patients: Hypothesis of possible significance
-
Dodson WL, Sachan DS, Krauss S, Hanna W: Alterations of serum and urinary carnitine profiles in cancer patients: hypothesis of possible significance. J Am Coll Nutr 1989; 8: 133-142.
-
(1989)
J Am Coll Nutr
, vol.8
, pp. 133-142
-
-
Dodson, W.L.1
Sachan, D.S.2
Krauss, S.3
Hanna, W.4
-
14
-
-
33845349279
-
Safety, tolerability and symptom outcomes associated with L -carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: A phase I/II study
-
Cruciani RA, Dvorkin E, Homel P, Malamud S, Culliney B, Lapin J, Portenoy RK, Esteban- Cruciani N: Safety, tolerability and symptom outcomes associated with L -carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study. J Pain Symptom Manage 2006; 32: 551-559.
-
(2006)
J Pain Symptom Manage
, vol.32
, pp. 551-559
-
-
Cruciani, R.A.1
Dvorkin, E.2
Homel, P.3
Malamud, S.4
Culliney, B.5
Lapin, J.6
Portenoy, R.K.7
Esteban- Cruciani, N.8
-
15
-
-
0033978634
-
Cancer and anticancer therapy-induced modifications on metabolism meditated by carnitine system
-
Peluso G, Nicolai R, Reda E, Bennati P, Barbarisi P, Calvani M: Cancer and anticancer therapy-induced modifications on metabolism meditated by carnitine system. J Cell Physiol 2002; 182: 339-350.
-
(2002)
J Cell Physiol
, vol.182
, pp. 339-350
-
-
Peluso, G.1
Nicolai, R.2
Reda, E.3
Bennati, P.4
Barbarisi, P.5
Calvani, M.6
-
16
-
-
0032925677
-
Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats
-
Visarius TM, Stucki JW, Lauterburg BH: Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats. J Pharmacol Exp Ther 1999; 289: 820-824.
-
(1999)
J Pharmacol Exp Ther
, vol.289
, pp. 820-824
-
-
Visarius, T.M.1
Stucki, J.W.2
Lauterburg, B.H.3
-
17
-
-
0019796279
-
Tissue specific depletion of L -carnitine in rat heart and skeletal muscle by D -carnitine
-
Paulson DJ, Shug AL: Tissue specific depletion of L -carnitine in rat heart and skeletal muscle by D -carnitine. Life Sci 1981; 28: 2931-2938.
-
(1981)
Life Sci
, vol.28
, pp. 2931-2938
-
-
Paulson, D.J.1
Shug, A.L.2
-
18
-
-
0023232325
-
L -Carnitine treatment improves cardiac performance and restores high energy phosphate pools in cardiomyopathic Syrian hamster
-
Whitmer JT: L -Carnitine treatment improves cardiac performance and restores high energy phosphate pools in cardiomyopathic Syrian hamster. Circ Res 1987; 61: 396-408.
-
(1987)
Circ Res
, vol.61
, pp. 396-408
-
-
Whitmer, J.T.1
-
19
-
-
0029001125
-
Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L -carnitine by D -carnitine and a -butyrobetaine hydroxylase inhibitor
-
Tsoko M, Beauseigneur F, Gresti J, Niot I, Demarquoy J, Boichot J, Bezard J, Rochette L, Clouet P: Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L -carnitine by D -carnitine and a -butyrobetaine hydroxylase inhibitor. Biochem Pharmacol 1995; 49: 1403-1410.
-
(1995)
Biochem Pharmacol
, vol.49
, pp. 1403-1410
-
-
Tsoko, M.1
Beauseigneur, F.2
Gresti, J.3
Niot, I.4
Demarquoy, J.5
Boichot, J.6
Bezard, J.7
Rochette, L.8
Clouet, P.9
-
20
-
-
0032940435
-
Pharmacokinetic analysis of the cardioprotective effect of 3-( 2, 2, 2-trimethylhydrazinium) propionate in mice: Inhibition of carnitine transport in kidney
-
Kuwajima M, Harashima H, Hayashi M, Ise S, Sei M, Lu K, Kiwada H, Sugiyama Y, Shima K: Pharmacokinetic analysis of the cardioprotective effect of 3-(2,2, 2-trimethylhydrazinium) propionate in mice: inhibition of carnitine transport in kidney. J Pharmacol Exp Ther 1999; 289: 93-102.
-
(1999)
J Pharmacol Exp Ther
, vol.289
, pp. 93-102
-
-
Kuwajima, M.1
Harashima, H.2
Hayashi, M.3
Ise, S.4
Sei, M.5
Lu, K.6
Kiwada, H.7
Sugiyama, Y.8
Shima, K.9
-
21
-
-
0034836831
-
Development and characterization of an animal model of carnitine deficiency
-
Spaniol M, Brooks H, Auer L, Zimmermann A, Solioz M, Stieger B, Krähenbühl S: Development and characterization of an animal model of carnitine deficiency. Eur J Biochem 2001; 268: 1876-1887.
-
(2001)
Eur J Biochem
, vol.268
, pp. 1876-1887
-
-
Spaniol, M.1
Brooks, H.2
Auer, L.3
Zimmermann, A.4
Solioz, M.5
Stieger, B.6
Krähenbühl, S.7
-
22
-
-
26444611260
-
Carnitine depletion in rat pups from mothers given mildronate: A model of carnitine deficiency in late fetal and neonatal life
-
Peschechera A, Scalibastri M, Russo F, Giarrizzo MG, Carminati P, Giannessi F, Arduini A, Ricciolini R: Carnitine depletion in rat pups from mothers given mildronate: a model of carnitine deficiency in late fetal and neonatal life. Life Sci 2005; 77: 3078-3091.
-
(2005)
Life Sci
, vol.77
, pp. 3078-3091
-
-
Peschechera, A.1
Scalibastri, M.2
Russo, F.3
Giarrizzo, M.G.4
Carminati, P.5
Giannessi, F.6
Arduini, A.7
Ricciolini, R.8
-
23
-
-
0017816152
-
Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate- to-lactate reactions in human serum at 25, 30, and 37 degrees C
-
Buhl SN, Jackson KY: Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate- to-lactate reactions in human serum at 25, 30, and 37 degrees C. Clin Chem 1978; 24: 828-831.
-
(1978)
Clin Chem
, vol.24
, pp. 828-831
-
-
Buhl, S.N.1
Jackson, K.Y.2
-
24
-
-
0019958463
-
Evaluation and comparison of immunoinhibition and immunoprecipitation methods for differentiating MB and BB from macro forms of creatine kinase isoenzymes in patients and healthy individuals
-
Wu AH, Bowers GN Jr: Evaluation and comparison of immunoinhibition and immunoprecipitation methods for differentiating MB and BB from macro forms of creatine kinase isoenzymes in patients and healthy individuals. Clin Chem 1982; 28: 2017-2021.
-
(1982)
Clin Chem
, vol.28
, pp. 2017-2021
-
-
Wu, A.H.1
Bowers Jr., G.N.2
-
25
-
-
33748978227
-
Determination of free and total carnitine in plasma by an enzymatic reaction and spectrophotometric quantitation spectrophotometric determination of carnitine
-
Prieto JA, Andrade F, Aldámiz-Echevarría L, Sanjurjo P: Determination of free and total carnitine in plasma by an enzymatic reaction and spectrophotometric quantitation spectrophotometric determination of carnitine. Clin Biochem 2006; 39: 1022-1027.
-
(2006)
Clin Biochem
, vol.39
, pp. 1022-1027
-
-
Prieto, J.A.1
Andrade, F.2
Aldámiz-Echevarría, L.3
Sanjurjo, P.4
-
26
-
-
0003024032
-
Preparation of mitochrondria from animal tissues and yeasts
-
Birnie GD (ed): ed 2. London Butterworths
-
Chappell JB, Hansford RG: Preparation of mitochrondria from animal tissues and yeasts; in Birnie GD (ed): Subcellular Components: Preparation and Fractionation. ed 2. London, Butterworths, 1969, pp 77-91.
-
(1969)
Subcellular Components: Preparation and Fractionation
, pp. 77-91
-
-
Chappell, J.B.1
Hansford, R.G.2
-
27
-
-
0017184389
-
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding
-
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976; 72: 248-254.
-
(1976)
Anal Biochem
, vol.72
, pp. 248-254
-
-
Bradford, M.M.1
-
28
-
-
0023856860
-
Quantitation of the effect of L -carnitine on the levels of acid-soluble short-chain acyl- CoA and CoASH in rat heart and liver mitochondria
-
Lysiak W, Lilly K, DiLisa F, Toth PP, Bieber LL: Quantitation of the effect of L -carnitine on the levels of acid-soluble short-chain acyl- CoA and CoASH in rat heart and liver mitochondria. J Biol Chem 1988; 263: 1151-1156.
-
(1988)
J Biol Chem
, vol.263
, pp. 1151-1156
-
-
Lysiak, W.1
Lilly, K.2
Dilisa, F.3
Toth, P.P.4
Bieber, L.L.5
-
29
-
-
0028346882
-
Analytical evaluation of high energy phosphate determination by high performance liquid chromatography in myocardial tissue
-
Botker HE, Kimose HH, Helligso P, Nielsen TT: Analytical evaluation of high energy phosphate determination by high performance liquid chromatography in myocardial tissue. J Mol Cell Cardiol 1994; 26: 41-48.
-
(1994)
J Mol Cell Cardiol
, vol.26
, pp. 41-48
-
-
Botker, H.E.1
Kimose, H.H.2
Helligso, P.3
Nielsen, T.T.4
-
30
-
-
3042934967
-
Tissue sulfhydryl groups
-
Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
-
(1959)
Arch Biochem Biophys
, vol.82
, pp. 70-77
-
-
Ellman, G.L.1
-
31
-
-
0018384650
-
Assay for lipid peroxides in animal tissues by thiobarbituric acid
-
Ohkawa H, Ohish N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid. Anal Biochem 1979; 95: 351-358.
-
(1979)
Anal Biochem
, vol.95
, pp. 351-358
-
-
Ohkawa, H.1
Ohish, N.2
Yagi, K.3
-
32
-
-
70349252134
-
Fulminant fatal cardiotoxicity following cyclophosphamide therapy
-
Katayama M, Imai Y , Hashimoto H, Kurata M, Nagai K, Tamita K, Morioka S, Furukawa Y: Fulminant fatal cardiotoxicity following cyclophosphamide therapy. J Cardiol 2009; 54: 330-334.
-
(2009)
J Cardiol
, vol.54
, pp. 330-334
-
-
Katayama, M.1
Imai, Y.2
Hashimoto, H.3
Kurata, M.4
Nagai, K.5
Tamita, K.6
Morioka, S.7
Furukawa, Y.8
-
33
-
-
67349280855
-
Oral glutamine protects against cyclophosphamide- induced cardiotoxicity in experimental rats through increase of cardiac glutathione
-
Todorova V, Vanderpool D, Blossom S, Nwokedi E, Hennings L, Mrak R, Klimberg VS: Oral glutamine protects against cyclophosphamide- induced cardiotoxicity in experimental rats through increase of cardiac glutathione. Nutrition 2009; 25: 812-817.
-
(2009)
Nutrition
, vol.25
, pp. 812-817
-
-
Todorova, V.1
Vanderpool, D.2
Blossom, S.3
Nwokedi, E.4
Hennings, L.5
Mrak, R.6
Klimberg, V.S.7
-
34
-
-
0025323320
-
Leakage of cytoplasmic enzymes from rat heart by the stress of cardiac beating after increase in cell membrane fragility by anoxia
-
Takami H, Matsuda H, Kuki S, Nishimura M, Kawashima Y, Watari H, Furuya E, Tagawa K: Leakage of cytoplasmic enzymes from rat heart by the stress of cardiac beating after increase in cell membrane fragility by anoxia. Pflugers Arch 1990; 416: 1-2.
-
(1990)
Pflugers Arch
, vol.416
, pp. 1-2
-
-
Takami, H.1
Matsuda, H.2
Kuki, S.3
Nishimura, M.4
Kawashima, Y.5
Watari, H.6
Furuya, E.7
Tagawa, K.8
-
36
-
-
58149471362
-
Neutrophil infiltration and oxidative stress may play a critical role in methotrexate- induced renal damage
-
Kolli WK, Abraham P, Isaac B, Selvakumar D: Neutrophil infiltration and oxidative stress may play a critical role in methotrexate- induced renal damage. Chemotherapy 2009; 55: 83-90.
-
(2009)
Chemotherapy
, vol.55
, pp. 83-90
-
-
Kolli, W.K.1
Abraham, P.2
Isaac, B.3
Selvakumar, D.4
-
37
-
-
54949101658
-
Protective effect of geranylgeranylacetone on cisplatin ototoxicity
-
Yin HY, Ma XF, Liu F, Xia M, Xu AT: Protective effect of geranylgeranylacetone on cisplatin ototoxicity. Chemotherapy 2009; 55: 1-5.
-
(2009)
Chemotherapy
, vol.55
, pp. 1-5
-
-
Yin, H.Y.1
Ma, X.F.2
Liu, F.3
Xia, M.4
Xu, A.T.5
-
38
-
-
0026631242
-
Interaction of carnitine with mitochondrial cardiolipin
-
Battelli D, Bellei M, Arrigoni-Martelli E, Muscatello U, Bobyleva V: Interaction of carnitine with mitochondrial cardiolipin. Biochim Biophys Acta 1992; 1117: 33-36.
-
(1992)
Biochim Biophys Acta
, vol.1117
, pp. 33-36
-
-
Battelli, D.1
Bellei, M.2
Arrigoni-Martelli, E.3
Muscatello, U.4
Bobyleva, V.5
-
39
-
-
0027453676
-
Sites of action of carnitine and its derivatives on the cardiovascular system: Interactions with membranes
-
Fritz IB, Arrigoni-Martelli E: Sites of action of carnitine and its derivatives on the cardiovascular system: interactions with membranes. Trends Pharmacol Sci 1993; 14: 355-360.
-
(1993)
Trends Pharmacol Sci
, vol.14
, pp. 355-360
-
-
Fritz, I.B.1
Arrigoni-Martelli, E.2
-
42
-
-
0032982416
-
L -Carnitine attenuates doxorubicin- Induced lipid peroxidation in rats
-
Luo X, Reichetzer B, Trines J, Benson LN, Lehotay DC: L -Carnitine attenuates doxorubicin- induced lipid peroxidation in rats. Free Radic Biol Med 1999; 26: 1158-1165.
-
(1999)
Free Radic Biol Med
, vol.26
, pp. 1158-1165
-
-
Luo, X.1
Reichetzer, B.2
Trines, J.3
Benson, L.N.4
Lehotay, D.C.5
-
43
-
-
0027459172
-
Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy
-
DOI 10.1002/mus.880160205
-
Campos Y, Huertas R, Lorenzo G, Bautista J, Gutierrez E, Aparicio M, Alesso L, Arenas J: Plasma carnitine insufficiency and effectiveness of L -carnitine therapy in patients with mitochondrial myopathy. Muscle Nerve 1993; 16: 150-153. (Pubitemid 23030999)
-
(1993)
Muscle and Nerve
, vol.16
, Issue.2
, pp. 150-153
-
-
Campos, Y.1
Huertas, R.2
Lorenzo, G.3
Bautista, J.4
Gutierrez, E.5
Aparicio, M.6
Alesso, L.7
Arenas, J.8
-
44
-
-
0028310835
-
Carnitine esters in metabolic disease
-
Bohles H, Evangeliou A, Bervoets K, Eckert I, Sewell A: Carnitine esters in metabolic disease. Eur J Pediatr 1994; 153:S57-S61.
-
(1994)
Eur J Pediatr
, vol.153
-
-
Bohles, H.1
Evangeliou, A.2
Bervoets, K.3
Eckert, I.4
Sewell, A.5
-
46
-
-
33750734282
-
Lupeol and its ester inhibit alteration of myocardial permeability in cyclophosphamide administered rats
-
Sudharsan PT, Mythili Y, Selvakumar E, Varalakshmi P: Lupeol and its ester inhibit alteration of myocardial permeability in cyclophosphamide administered rats. Mol Cell Biochem 2006; 292: 39-44.
-
(2006)
Mol Cell Biochem
, vol.292
, pp. 39-44
-
-
Sudharsan, P.T.1
Mythili, Y.2
Selvakumar, E.3
Varalakshmi, P.4
-
48
-
-
0031766909
-
Increased urinary excretion of carnitine in patients treated with cisplatin
-
Heuberger W, Berardi S, Jacky E, Pey P, Krä henbuhl S: Increased urinary excretion of carnitine in patients treated with cisplatin. Eur J Clin Pharmacol 1998; 54: 503-508.
-
(1998)
Eur J Clin Pharmacol
, vol.54
, pp. 503-508
-
-
Heuberger, W.1
Berardi, S.2
Jacky, E.3
Pey, P.4
Krä Henbuhl, S.5
-
49
-
-
56049117823
-
Carnitine deficiency aggravates carboplatin nephropathy through deterioration of energy status, oxidant/anti-oxidant balance, and inflammatory endocoids
-
Arafa HM: Carnitine deficiency aggravates carboplatin nephropathy through deterioration of energy status, oxidant/anti-oxidant balance, and inflammatory endocoids. Toxicology 2008; 254: 51-60.
-
(2008)
Toxicology
, vol.254
, pp. 51-60
-
-
Arafa, H.M.1
-
50
-
-
8344279500
-
Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model
-
Sayed-Ahmed MM, Eissa MA, Kenawy SA, Mostafa N, Calvani M, Osman AM: Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model. Chemotherapy 2004; 50: 162-170.
-
(2004)
Chemotherapy
, vol.50
, pp. 162-170
-
-
Sayed-Ahmed, M.M.1
Eissa, M.A.2
Kenawy, S.A.3
Mostafa, N.4
Calvani, M.5
Osman, A.M.6
-
51
-
-
0033729907
-
Pharmacokinetics of propionyl- L -carnitine in humans: Evidence for saturable tubular reabsorption
-
Pace S, Longo A, Toon S, Rolan P, Evans AM: Pharmacokinetics of propionyl- L -carnitine in humans: evidence for saturable tubular reabsorption. Br J Clin Pharmacol 2000; 50: 441-448.
-
(2000)
Br J Clin Pharmacol
, vol.50
, pp. 441-448
-
-
Pace, S.1
Longo, A.2
Toon, S.3
Rolan, P.4
Evans, A.M.5
-
52
-
-
0028982336
-
Disposition of L -carnitine and acetyl- L - Carnitine in the isolated perfused rat kidney
-
Mancinelli A, Longo A, Shanahan K, Evans AM: Disposition of L -carnitine and acetyl- L - carnitine in the isolated perfused rat kidney. J Pharmacol Exp Ther 1995; 274: 1122-1128.
-
(1995)
J Pharmacol Exp Ther
, vol.274
, pp. 1122-1128
-
-
Mancinelli, A.1
Longo, A.2
Shanahan, K.3
Evans, A.M.4
-
53
-
-
0030925428
-
Excretion and metabolism of propionyl- L -carnitine in the isolated perfused rat kidney
-
Evans AM, Mancinelli A, Longo A: Excretion and metabolism of propionyl- L -carnitine in the isolated perfused rat kidney. J Pharmacol Exp Ther 1997; 281: 1071-1076.
-
(1997)
J Pharmacol Exp Ther
, vol.281
, pp. 1071-1076
-
-
Evans, A.M.1
Mancinelli, A.2
Longo, A.3
-
54
-
-
0034911794
-
Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide
-
Dubourg L, Michoudet C, Cochat P, Baverel G: Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide. J Am Soc Nephrol 2001; 12: 1615-1623.
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 1615-1623
-
-
Dubourg, L.1
Michoudet, C.2
Cochat, P.3
Baverel, G.4
-
55
-
-
1842389677
-
Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle
-
Neely JR, Morgan HE: Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 1974; 36: 413-459.
-
(1974)
Annu Rev Physiol
, vol.36
, pp. 413-459
-
-
Neely, J.R.1
Morgan, H.E.2
-
56
-
-
0344074048
-
Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats
-
Visarius TM, Bähler H, Küpfer A, Cerny T, Lauterburg BH.: Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats. Drug Metab Dispos 1998; 26: 193-196.
-
(1998)
Drug Metab Dispos
, vol.26
, pp. 193-196
-
-
Visarius, T.M.1
Bähler, H.2
Küpfer, A.3
Cerny, T.4
Lauterburg, B.H.5
-
57
-
-
0032925677
-
Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats
-
Visarius TM, Stucki JW, Lauterburg BH: Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats. J Pharmacol Exp Ther 1999; 289: 820-824.
-
(1999)
J Pharmacol Exp Ther
, vol.289
, pp. 820-824
-
-
Visarius, T.M.1
Stucki, J.W.2
Lauterburg, B.H.3
-
58
-
-
85047675973
-
Protection of the ischaemic myocardium by L -propionylcarnitine: Effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation
-
Paulson DJ, Traxler J, Schmidt M, Noonan J, Shug AL: Protection of the ischaemic myocardium by L -propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation. Cardiovasc Res 1986; 20: 536-541.
-
(1986)
Cardiovasc Res
, vol.20
, pp. 536-541
-
-
Paulson, D.J.1
Traxler, J.2
Schmidt, M.3
Noonan, J.4
Shug, A.L.5
-
59
-
-
10644296223
-
Therapeutic effects of L -carnitine and propionyl- L -carnitine on cardiovascular diseases: A review
-
Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C: Therapeutic effects of L -carnitine and propionyl- L -carnitine on cardiovascular diseases: a review. Ann NY Acad Sci 2004; 1033: 79-91.
-
(2004)
Ann NY Acad Sci
, vol.1033
, pp. 79-91
-
-
Ferrari, R.1
Merli, E.2
Cicchitelli, G.3
Mele, D.4
Fucili, A.5
Ceconi, C.6
-
60
-
-
0034942177
-
Propionyl- L -carnitine as protector against Adriamycin-induced cardiomyopathy
-
Sayed-Ahmed MM, Salman TM, Gaballah HE, Abou El-Naga SA, Nicolai R, Calvani M: Propionyl- L -carnitine as protector against Adriamycin-induced cardiomyopathy. Pharmacol Res 2001; 43: 513-520.
-
(2001)
Pharmacol Res
, vol.43
, pp. 513-520
-
-
Sayed-Ahmed, M.M.1
Salman, T.M.2
Gaballah, H.E.3
Abou El-Naga, S.A.4
Nicolai, R.5
Calvani, M.6
-
61
-
-
0036715482
-
L -Carnitine inhibits cisplatin-induced injury of the kidney and small intestine
-
Chang B, Nishikawa M, Sato E, Utsumi K, Inoue M: L -Carnitine inhibits cisplatin-induced injury of the kidney and small intestine. Arch Biochem Biophys 2002; 405: 55-64.
-
(2002)
Arch Biochem Biophys
, vol.405
, pp. 55-64
-
-
Chang, B.1
Nishikawa, M.2
Sato, E.3
Utsumi, K.4
Inoue, M.5
|